Reduction of a platinum(iv) prodrug model by sulfur containing biological reductants: computational mechanistic elucidation

Antony Chipman, Brian F. Yates, Allan J. Canty, Alireza Ariafard*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Abstract

A PtIV prodrug needs to be reduced to PtII by a biomolecule in order to show efficacy. Among biomolecules, those containing an l-Cys residue have the highest potential to be involved in reduction. Tautomerisation from HSCH2CH(NH3+)CO2 to the unusual zwitterion form SCH2CH(NH3+)CO2H is the prerequisite for l-Cys to become a potent reductant at a low pH.

Original languageEnglish
Pages (from-to)10491-10494
Number of pages4
JournalChemical Communications
Volume54
Issue number74
DOIs
Publication statusPublished - 2018
Externally publishedYes

Fingerprint

Dive into the research topics of 'Reduction of a platinum(iv) prodrug model by sulfur containing biological reductants: computational mechanistic elucidation'. Together they form a unique fingerprint.

Cite this